Association between bh4/bh2 ratio and Albuminuria in Hypertensive Type -2 Diabetic patients

Main Article Content

Jose Aviles-Herrera
Karla C Arana-Pazos
Leonardo Del Valle-Mondragon
Carolina Guerrero-García
Alberto Francisco Rubio-Guerra*

Abstract

Endothelial dysfunction and inflammation play a key role in the pathophysiology of diabetic nephropathy; Tetrahydrobiopterin (BH4) is an essential cofactor for nitric oxide synthase, when BH4 is reduced to dihydrobiopterin (BH2), endothelial dysfunction is induced.


Purpose: The aim of this study is to evaluate the relationship between the levels of biopterins with albuminuria in type-2 diabetic hypertensive patients.


Methods: We studied 30 hypertensive type-2 diabetic patients in whom biopterins levels were measured by reverse phase high performance liquid chromatography with fluorescence detection. Additionally, 24 h urinary albumin excretion was also measured (nephelometry). The levels of biopterins and albuminuria were correlated with the Pearson correlation coefficient.


Results: We did not find a significantly correlation between biopterins levels and albuminuria, However, we found a significantly inverse correlation (R= -0.498, p<0.005) between the BH4/BH2 ratio and albuminuria.


Conclusion: Our results suggest that the BH4/BH2 ratio instead of biopterins levels may be a marker of nephropathy in hypertensive type-2 diabetic patients.

Article Details

Aviles-Herrera, J., Arana-Pazos, K. C., Valle-Mondragon, L. D., Guerrero-García, C., & Rubio-Guerra, A. F. (2017). Association between bh4/bh2 ratio and Albuminuria in Hypertensive Type -2 Diabetic patients. Journal of Clinical Nephrology, 1(1), 060–063. https://doi.org/10.29328/journal.jcn.1001009
Research Articles

Copyright (c) 2017 Herrera JA, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The Journal of Clinical Nephrology is committed in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. In order to use the Open Access paradigm to the maximum extent in true terms as free of charge online access along with usage right, we grant usage rights through the use of specific Creative Commons license.

License: Copyright © 2017 - 2025 | Creative Commons License Open Access by Journal of Clinical Nephrology is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at Heighten Science Publications Inc.

With this license, the authors are allowed that after publishing with the journal, they can share their research by posting a free draft copy of their article to any repository or website.

Compliance 'CC BY' license helps in:

Permission to read and download
Permission to display in a repository
Permission to translate
Commercial uses of manuscript

'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license. 

Walker JD. An update on diabetic renal disease. Br J Diabetes Vasc Dis. 2010; 10: 219-223. Ref.: https://goo.gl/tuKN34

Rubio AF, Vargas H, Lozano JJ, Escalante BA. Corrrelation between circulating adhesión molecules levels and albuminuria in type 2 diabetic hypertensive patients. Kydney Blood Press Res. 2009; 32: 106-109. Ref.: https://goo.gl/Hez4TN

Rubio-Guerra AF, Vargas-Robles H. Ramos-Brizuela LM. Escalante-Acosta BA. Is tetrahydrobiopterin a therapeutic option in diabetic hypertensive patients? Integr Blood Press Control. 2010; 3: 125-132. Ref.: https://goo.gl/zwyA7u

Takeda M, Yamashita T, Shinohara M, Sasaki N, Takaya T. Nakajima K et al. Plasma tetrahydrobiopterin/dihydrobiopterin ratio. A posible marker of endothelial dysfunction. Cir J. 2009; 955-962. Ref.: https://goo.gl/osbbAE

Bauersachs J, Widder JD. Tetrahydrobiopterin, endothelial nitric oxide synthase, and mitochondrial function in the heart. Hypertension. 2009; 53: 907-908. Ref.: https://goo.gl/CCUCjF

ChanWB, Chan NN, Lai CW, So WY, Lo MK, et al. Vascular defect beyond the endothelium in type II diabetic patients with overt nephropathy and moderate renal insufficiency. Kidney International. 2006; 70: 711-716. Ref.: https://goo.gl/YhMdFA

Lim SC, Logerfo FW, Caballero AE, Horton ES, Smakowski P, et al. Soluble intercellular molecule, vascular C adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes care. 1999; 22: 1865-1870. Ref.: https://goo.gl/P35yJp

Taslipinar A, Yaman H, Ilker M, Demirbas S, Saglam M, et al. The relationship between inflammation, endothelial dysfunction and proteinuria in patients with diabetic nephropathy. Scan J Clin & Lab Invest. 2011; 71: 606-612. Ref.: https://goo.gl/bwMGrD

Rubio-Guerra AF, Vargas-Robles H, Del Valle-Mondragon L, Lozano-Nuevo JJ, Escalante-Acosta BA. Association between the levels of circulating adhesion molecules and biopterins in type-2 diabetic normotensive patients adhesion molecules and biopterins. Endocr Metab Immune Disord Drug Targets. 2012; 12: 243-246. Ref.: https://goo.gl/5FDzXL